← Back to Clinical Trials
Recruiting NCT05616481

NCT05616481 Laparoscopic Burch Colposuspension Versus Modified Burch Colposuspension

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05616481
Status Recruiting
Phase —
Sponsor Al-Azhar University
Condition Stress Urinary Incontinence
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2022-01-01
Primary Completion 2025-06

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Laparoscopic Burch colposuspensionModefied Burch (TOT - like)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2022-01-01 with a primary completion date of 2025-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the success rate and complications following laparoscopic standard Burch colposuspension and laparoscopic modified Burch colposuspension (Transobturator tape like)

Eligibility Criteria

Inclusion Criteria: * Women with genuine stress urinary incontinence. * Mixed urinary incontinence with predominant stress element. * Refractory cases to conservative therapy or patients who are not willing to consider (further) conservative treatment. Exclusion Criteria: * Mixed incontinence with predominant Urge urinary incontinence. * Recent pelvic surgery (less than 3 months). * Neurogenic lower urinary tract dysfunction. * Previous surgery for stress urinary incontinence. * Pregnancy * Less than 12 months post-partum. * Other gynaecologic pathologies affecting bladder functions ( eg, fibroids, ovarian cysts) * Genito-urinary malignancy. * Current chemo or radiation therapy.

Contact & Investigator

Central Contact

Mohamed Fawzy Salman, MD

✉ prof_mohamed_fawzy@yahoo.com

📞 +201111788996

Frequently Asked Questions

Who can join the NCT05616481 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Stress Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05616481 currently recruiting?

Yes, NCT05616481 is actively recruiting participants. Contact the research team at prof_mohamed_fawzy@yahoo.com for enrollment information.

Where is the NCT05616481 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT05616481 clinical trial?

NCT05616481 is sponsored by Al-Azhar University. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology